Blog

Dr. Jose Barrera Publishes FDA-Approved Vivaer Study Comparing Temperature-Controlled Radiofrequency to Nasal Airway Surgery

Patients struggling with chronic nasal obstruction often assume surgery is their only option. However, new research published by Dr. Jose Barrera and fellow investigators is helping reshape that conversation.

Dr. Barrera recently contributed to the publication of “Temperature-Controlled Radiofrequency (Vivaer) for Severe Nasal Airway Obstruction: A Non-Inferiority Comparison with Surgical Intervention” in the International Forum of Allergy & Rhinology, one of the leading peer-reviewed journals in the field.

The study evaluated the effectiveness of the FDA-approved Vivaer® treatment for patients with severe nasal airway obstruction and compared outcomes against traditional surgical intervention.

What Is Vivaer®?

Vivaer® is a minimally invasive, temperature-controlled radiofrequency treatment designed to improve nasal breathing by remodeling tissue inside the nasal valve area, one of the most common causes of chronic nasal obstruction.

<